• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for Technology Ventures News

Technology Ventures News

Shah joins OMRF Technology Ventures

January 4, 2021

At OMRF, Shah will serve as a technology development specialist.

Filed Under: News, Technology Ventures News Tagged With: accele, biopharma, biopharmaceutical, center, company, drug, health, hemangi shah, industry, Oklahoma Medical Research Foundation, OMRF, OUHSC, patent, pharmaceutical, post-doc, science, scientist-news, tech ventures, technology

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

Progentec Raises $5M in Series A Funding Led by Plains Venture Partners

January 12, 2020

Seeking new ways to help patients manage lupus

Filed Under: Technology Ventures News

New use for OMRF brain cancer treatment could extend lives

December 18, 2019

In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.

Filed Under: News, Technology Ventures News Tagged With: battiste, brain cancer, cancer, center, chemo, drug, glioblastoma, James, Manu Nair, newsok, OKC, Oklahoma Medical Research Foundation, OKN-007, OMRF, ou, OUHSC, patient, Rheal, scientist-news, stephenson, technology ventures, temodar, therapy, Towner, treatment, university of oklahoma

FDA approves new sickle cell drug with Oklahoma roots

November 18, 2019

Adakveo significantly reduces pain crises in sickle cell patients.

Filed Under: News, Technology Ventures News Tagged With: Adakveo, FDA, FDA approval, McEver, novartis, P-selectin, pain crises, rodger, Rodger McEver, scd, scientist-news, selexys, sickle cell, sickle cell disease

Progentec Raises Funds to Support Advances in Lupus Detection and Management

November 7, 2018

The funding will help bring Progentec’s tool for identifying lupus flare ups and a biomarker-based disease-activity index closer to commercialization.

Filed Under: Technology Ventures News

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace